Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
de Jong-van den Berg
Observed names:
De Jong‐Van den Berg,
De Jong‐van den Berg,
L T W de Jong-van den Berg,
L T de Jong-van den Berg,
L.T.W. de Jong-van den Berg
Observed institution:
University of Groningen
OpenAlex ID:
A5113487105
Drug and Therapeutics (D & T) committees in Dutch hospitals: a nation‐wide survey of structure, activities, and drug selection procedures
1999
·
Fijn
, Brouwers
, et al.
·
British Journal of Clinical Pharmacology
·
49
PDF
The Dutch ‘Folic Acid Campaign’–have the goals been achieved?
2000
·
Van Der Pal‐de Bruin
, De Walle
, et al.
·
Paediatric and Perinatal Epidemiology
·
43
Additional information from parental questionnaires and pharmacy records for registration of birth defects
2000
·
J. Reefhuis
, H.E.K. de Walle
, et al.
·
European Journal of Epidemiology
·
11
[Screening for asymptomatic Chlamydia trachomatis infection in pregnancy; cost-effectiveness favorable at a minimum prevalence rate of 3% or more].
2000
·
M J Postma
, A Bakker
, et al.
·
PubMed
·
8
[Pregnancy and drug use].
1992
·
B Meyboom-de Jong
, L T de Jong-van den Berg
·
PubMed
·
2
[Deptropine still prescribed for 0-4 year olds].
2000
·
E Schirm
, H J Gebben
, et al.
·
PubMed
·
1
[Uncertain effects of folic acid on disorders other than neural-tube defects].
2006
·
D J de Smit
, L T W de Jong-van den Berg
·
PubMed
[Teratogenic risks of high-dosage vitamin A].
1992
·
G J Knijn
, M C Cornel
, et al.
·
PubMed
Show more works
View as search
Works count:
8
Citation count:
114
H-index:
4
I10-index:
3
Year
Topic
Type
